Autoimmune Endocrine Disease Related Antibodies Before the Start of Immune Checkpoint Inhibitor Therapy

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

November 14, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Autoimmunity
Interventions
OTHER

Blood sampling

For the analysis of the autoimmune endocrine disease related antibodies (Ab) before the start of the immunotherapy, a blood sample will be collected aligned with the first visit with the treating gastro-enterologist/oncologist/pneumologist for analysis of: anti-thyroglobulin Ab (aTg), anti-thyroperoxidase Ab (aTPO), TSH receptor antibodies (TRAb), pituitary Ab, adrenal Ab, and anti-glutamic acid decarboxylase (GAD) Ab.

Trial Locations (3)

1000

RECRUITING

C.H.U. Saint-Pierre, Brussels

1020

RECRUITING

CHU Brugmann, Brussels

1070

RECRUITING

HUB - Institut Jules Bordet, Brussels

All Listed Sponsors
lead

Laura ICONARU

OTHER